We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GMEX:NASDAQGMEX ROBOTICS CORPORATION Analysis

Data as of 2026-04-06 - not real-time

$0.52

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook is bearish: the short‑term moving average sits below the medium‑term average, the RSI is in oversold territory, and the MACD line remains under its signal. Price action is hugging a key support level while volatility has spiked to extreme levels, and the market cap remains minuscule, indicating limited liquidity. Fundamentals are weak with negative earnings, operating cash flow deficits, and a dividend yield that appears unsustainable given the cash‑flow profile. Valuation metrics suggest a massive gap between the discounted cash‑flow fair value and the current price, hinting at potential upside if the business can turn around. Risk factors are pronounced, including high price swings, sector competition, and concentration in a single geography.
The recent AU$4.2 million commercial contract to deploy AI kitchen robots provides a tangible catalyst that could improve revenue momentum and support the undervaluation thesis. However, the company’s limited employee base, ongoing losses, and high leverage temper enthusiasm. Investors should weigh the upside from the new order against the structural challenges and liquidity constraints before deciding on exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators
  • Price near recent support
  • Recent commercial order but limited liquidity

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant valuation gap to DCF fair value
  • New AI robot contract could drive revenue growth
  • Potential for turnaround if cash flow improves

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Persistently negative earnings and margins
  • High volatility and liquidity constraints
  • Uncertain scalability of the business model

Key Metrics & Analysis

Financial Health

Revenue Growth8.90%
Profit Margin-13.13%
ROE-7.50%
ROA-5.58%
Debt/Equity3.42
P/B Ratio0.0
Op. Cash Flow$-1016390
Free Cash Flow$921.2K
Industry P/E33.5

Technical Analysis

TrendBearish
RSI28.5
Support$0.45
Resistance$1.95
MA 20$1.05
MA 50$1.70
MA 200$31.49
MACDBearish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

Fair Value$11.54
GradeUndervalued
TypeValue
Dividend Yield154.44%

Risk Assessment

Beta0.86
Volatility206.90%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.